<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04876898</url>
  </required_header>
  <id_info>
    <org_study_id>BMI_COVID19</org_study_id>
    <nct_id>NCT04876898</nct_id>
  </id_info>
  <brief_title>High Body Mass Index and Severity of Coronavirus</brief_title>
  <official_title>High Body Mass Index and Severity of Coronavirus Disease 2019 (Covid-19): a Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>South Valley University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI&#xD;
      levels on admission: overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2,&#xD;
      35-39.9 kg/m2, 40-44.9 kg/m2, and ≥45 kg/m2).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">January 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>pneumonia</measure>
    <time_frame>30 days</time_frame>
    <description>patients percentages</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sever pneumonia</measure>
    <time_frame>30 days</time_frame>
    <description>patients percentages</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ICU admission</measure>
    <time_frame>30 days</time_frame>
    <description>patients percentages</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical complication</measure>
    <time_frame>30 days</time_frame>
    <description>patients percentages</description>
  </secondary_outcome>
  <enrollment type="Actual">114</enrollment>
  <condition>COVID-19 Pneumonia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prospective cohort in high body mass index patient with covid 19</intervention_name>
    <description>A cohort study included 114 adult patients with confirmed COVID-19 were categorized by BMI levels</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        114 adult patients with confirmed COVID-19 were categorized by BMI levels on admission:&#xD;
        overweight (25-29.9 kg/m2), and obesity (four categories: 30-34.9 kg/m2, 35-39.9 kg/m2,&#xD;
        40-44.9 kg/m2, and ≥45 kg/m2). Pneumonia, severe pneumonia, and ICU admission rate were our&#xD;
        primary outcomes, complications, and length of hospital stay was the secondary outcome.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients older than 18 years&#xD;
&#xD;
          -  confirmed COVUID 19 infection&#xD;
&#xD;
          -  body mass index more than 25kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gad S Gad, phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>ass prof ,anesthesia and ICU ,south valley university,Qena .Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gad sayed Gad</name>
      <address>
        <city>Qinā</city>
        <state>Qena</state>
        <zip>83511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>South Valley University</investigator_affiliation>
    <investigator_full_name>Gad Sayed Gad</investigator_full_name>
    <investigator_title>ass.prof anesthesia department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

